EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pyrroloquinoline quinone alleviates natural aging‐related osteoporosis via a novel MCM3‐Keap1‐Nrf2 axis‐mediated stress response and Fbn1 upregulation

Jie Li, Jing Zhang, Qi Xue, Boyang Liu, Ran Qin, Yiping Li, Yue Qiu, Rong Wang, David Goltzman, Dengshun Miao iD, Renlei Yang

Aging Cell · 2023-09 · 22 (9)

DOI: 10.1111/acel.13912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Aging Cell, online erschienen am 26.06.2023. Verfasst von Jie Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, Affiliated Friendship Plastic Surgery Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, Chi…. Hauptthemen laut MEDLINE: Osteoporosis, Bone Resorption. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Age‐related osteoporosis is associated with increased oxidative stress and cellular senescence. Pyrroloquinoline quinone (PQQ) is a water‐soluble vitamin‐like compound that has strong antioxidant capacity; however, the effect and underlying mechanism of PQQ on aging‐related osteoporosis remain unclear. The purpose of this study was to investigate whether dietary PQQ supplementation can prevent osteoporosis caused by natural aging, and the potential mechanism underlying PQQ antioxidant activity. Here, we found that when 6‐month‐old or 12‐month‐old wild‐type mice were supplemented with PQQ for 12 months or 6 months, respectively, PQQ could prevent age‐related osteoporosis in mice by inhibiting osteoclastic bone resorption and stimulating osteoblastic bone formation. Mechanistically, pharmmapper screening and molecular docking studies revealed that PQQ appears to bind to MCM3 and reduces its ubiquitination‐mediated degradation; stabilized MCM3 then competes with Nrf2 for binding to Keap1, thus activating Nrf2‐antioxidant response element (ARE) signaling. PQQ‐induced Nrf2 activation inhibited bone resorption through increasing stress response capacity and transcriptionally upregulating fibrillin‐1 (Fbn1), thus reducing Rankl production in osteoblast‐lineage cells and decreasing osteoclast activation; as well, bone formation was stimulated by inhibiting osteoblastic DNA damage and osteocyte senescence. Furthermore, Nrf2 knockout significantly blunted the inhibitory effects of PQQ on oxidative stress, on increased osteoclast activity and on the development of aging‐related osteoporosis. This study reveals the underlying mechanism of PQQ's strong antioxidant capacity and provides evidence for PQQ as a potential agent for clinical prevention and treatment of natural aging‐induced osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteoporosisBone ResorptionMiceAnimalsAntioxidantsPQQ CofactorNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1Up-RegulationFibrillin-1Molecular Docking SimulationOxidative StressAging

Stichwörter der Autor:innen

Fbn1Keap1-Nrf2 signalingagingosteoporosispyrroloquinoline quinone

Substanzen

AntioxidantsPQQ CofactorNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1Fibrillin-1Keap1 protein, mouse

Autor:innen und Institutionen

  • Department of Plastic Surgery, Affiliated Friendship Plastic Surgery Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing, China.
  • Department of Anatomy, Histology and Embryology, State Key Laboratory of Reproductive Medicine, The Research Center for Bone and Stem Cells, Nanjing Medical University, Nanjing, China.
  • Calcium Research Laboratory, McGill University Health Centre and Department of Medicine, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Dengshun Miao

Förderung

  • Canadian Institutes of Health Research
  • National Natural Science Foundation of China

Zitieren

APA

Li, J., Zhang, J., Xue, Q., Liu, B., Qin, R., Li, Y., Qiu, Y., Wang, R., Goltzman, D., Miao, D., & Yang, R. (2023). Pyrroloquinoline quinone alleviates natural aging‐related osteoporosis via a novel MCM3‐Keap1‐Nrf2 axis‐mediated stress response and Fbn1 upregulation. Aging Cell, 22(9). https://doi.org/10.1111/acel.13912

Vancouver

Li J, Zhang J, Xue Q, Liu B, Qin R, Li Y, et al. Pyrroloquinoline quinone alleviates natural aging‐related osteoporosis via a novel MCM3‐Keap1‐Nrf2 axis‐mediated stress response and Fbn1 upregulation. Aging Cell. 2023;22(9). doi:10.1111/acel.13912

BibTeX
@article{Li2023,
  author = {Li, Jie and Zhang, Jing and Xue, Qi and Liu, Boyang and Qin, Ran and Li, Yiping and Qiu, Yue and Wang, Rong and Goltzman, David and Miao, Dengshun and Yang, Renlei},
  title = {Pyrroloquinoline quinone alleviates natural aging‐related osteoporosis via a novel MCM3‐Keap1‐Nrf2 axis‐mediated stress response and Fbn1 upregulation},
  journal = {Aging Cell},
  year = {2023},
  volume = {22},
  number = {9},
  doi = {10.1111/acel.13912}
}
Kostenlos starten →